Thiopurine Immunomodulators in Ulcerative Colitis: Moving Forward with Current Evidence

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|12|10|1406-1412

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.10, 2011-09, pp. : 1406-1412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current therapy of ulcerative colitis in children

By Bremner Alan Ronald   Griffiths David Mervyn   Beattie Robert Mark  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 37-53

Informa Healthcare

Access to resources Recommend Favorite

Natural History of Ulcerative Colitis: Current Knowledge

By  

Current Drug Targets, Vol. 12, Iss. 10, 2011-01 ,pp. : 1390-1395

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Tumour Necrosis Factor Therapy for Ulcerative Colitis: Evidence to Date

By Thukral Chandrashekhar   Cheifetz Adam   Peppercorn Mark A.  

Drugs, Vol. 66, Iss. 16, 2006-01 ,pp. : 2059-2065

Adis International

Access to resources Recommend Favorite

Ulcerative Colitis: Pathogenesis

By  

Current Drug Targets, Vol. 12, Iss. 10, 2011-09 ,pp. : 1373-1382

Bentham Science Publishers

Access to resources Recommend Favorite

Critical Review of the Evidence on 5-Aminosalicilate for Chemoprevention of Colorectal Cancer in Ulcerative Colitis: A Methodological Question

By  

Current Clinical Pharmacology, Vol. 9, Iss. 1, 2014-02 ,pp. : 84-90

Bentham Science Publishers

Access to resources Recommend Favorite